On Jan. 29, Janssen—the vaccine-making subsidiary of the pharma giant Johnson & Johnson—announced data from its phase 3 clinical trial for its Covid-19 vaccine.Janssen’s clinical trial tracked participants after they only got just one dose of its vaccine, a potentially sizable advantage. All other vaccines available or in late stage clinical trials require two doses—which complicates the logistics of distribution. On top of that, Janssen’s shot only requires regular refrigeration to be shipped and stored. Together, those two factors could make it significantly easier to quickly inoculate large swaths of the global population.In a press conference, Janssen announced that it’d be reporting the
Hence then, the article about everything we know about johnson johnson s single dose covid 19 vaccine was published today ( ) and is available onQuartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Everything we know about Johnson & Johnson’s single-dose Covid-19 vaccine )